APVO - アプテボ・セラピュ―ティクス (Aptevo Therapeutics Inc.) アプテボ・セラピュ―ティクス

 APVOのチャート


 APVOの企業情報

symbol APVO
会社名 Aptevo Therapeutics Inc (アプテボ・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アプテボ・セラピューティクス(Aptevo Therapeutics Inc.)はバイオ技術会社である。同社は患者の生命を管理するためにオンコロジー(がん)及び血液学(血液疾患)治療薬の生産に従事する。同社の事業はオンコロジー及び血液学治療薬の発見・開発・商品化・販売を行う。核心技術はADAPTIS(モジュラータンパク質技術)プラットフォームである。同社は血液学と感染症分野で約4つの製品を有し、並びに免疫腫瘍学における多様な治験段階の製品候補を有する。その治験段階の製品候補であるMOR209/ES414、ES210、ES425及びotlertuzumabはADAPTISプラットフォーム上に構築される。同社の販売製品は「WinRho SDF」(抗 D(Rho)ヒト免疫グロブリン)、「HepaGam B」(B型肝炎ヒト免疫グロブリン)、「VARIZIG」(水痘帯状疱疹ヒト免疫グロブリン)及び「IXINITY」(血液凝固第IX因子(組換え型))である。   アプテボ・セラピュ―ティクスは米国のバイオ医薬品企業。主にがんと血液疾患に対し、同社開発のモジュラ―・タンパク質技術「ADAPTIR」による治療に従事する。がん治療、免疫療法に利用される候補薬に「MOR209/ES414」、「ES210」、「ES425」、「Otlertuzumab」などを含む。本社はワシントン州シアトル。   Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
本社所在地 2401 4th Avenue Suite 1050 Seattle WA 98121 USA
代表者氏名
代表者役職名
電話番号 +1 206-838-0500
設立年月日 42401
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 121人
url www.AptevoTherapeutics.com
nasdaq_url https://www.nasdaq.com/symbol/apvo
adr_tso
EBITDA EBITDA(百万ドル) -50.97500
終値(lastsale) 4.6
時価総額(marketcap) 104279263
時価総額 時価総額(百万ドル) 102.46570
売上高 売上高(百万ドル) 19.88700
企業価値(EV) 企業価値(EV)(百万ドル) 77.30170
当期純利益 当期純利益(百万ドル) -33.79400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Aptevo Therapeutics Inc revenues increased 92% to $10.9M. Net loss before extraordinary items increased 5% to $27.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing increase of 52% to $17.4M (expense) Other expense from continuing operations increase of 22% to $1.1M (expense).

 APVOのテクニカル分析


 APVOのニュース

   Aptevo Therapeutics collects $0.75M working capital escrow (NASDAQ:APVO)  2020/06/29 13:51:25 Seeking Alpha
Aptevo Therapeutics (APVO +4.6%) collects in full $0.75M placed into an escrow account for working capital adjustments. This collection relates to the Comp
   Aptevo rallies on royalty stream from rituximab biosimilar (NASDAQ:APVO)  2020/06/25 19:27:16 Seeking Alpha
Thinly traded nano cap Aptevo Therapeutics (APVO +45.0%) jumps on a whopping 292x surge in volume in reaction to its announcement that it will receive a ro
   Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?  2020/06/25 14:35:00 PR Newswire
NEW YORK, June 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EKSO, AAPL, GNC, MSFT, and APVO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar  2020/06/25 13:00:00 Yahoo Finance
SEATTLE, WA / ACCESSWIRE / June 25, 2020 / Aptevo Therapeutics Inc. (APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will receive a royalty from Pfizer related to sales of
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   Aptevo Therapeutics collects $0.75M working capital escrow (NASDAQ:APVO)  2020/06/29 13:51:25 Seeking Alpha
Aptevo Therapeutics (APVO +4.6%) collects in full $0.75M placed into an escrow account for working capital adjustments. This collection relates to the Comp
   Aptevo rallies on royalty stream from rituximab biosimilar (NASDAQ:APVO)  2020/06/25 19:27:16 Seeking Alpha
Thinly traded nano cap Aptevo Therapeutics (APVO +45.0%) jumps on a whopping 292x surge in volume in reaction to its announcement that it will receive a ro
   Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?  2020/06/25 14:35:00 PR Newswire
NEW YORK, June 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EKSO, AAPL, GNC, MSFT, and APVO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar  2020/06/25 13:00:00 Yahoo Finance
SEATTLE, WA / ACCESSWIRE / June 25, 2020 / Aptevo Therapeutics Inc. (APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will receive a royalty from Pfizer related to sales of
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   Aptevo Therapeutics collects $0.75M working capital escrow (NASDAQ:APVO)  2020/06/29 13:51:25 Seeking Alpha
Aptevo Therapeutics (APVO +4.6%) collects in full $0.75M placed into an escrow account for working capital adjustments. This collection relates to the Comp
   Aptevo rallies on royalty stream from rituximab biosimilar (NASDAQ:APVO)  2020/06/25 19:27:16 Seeking Alpha
Thinly traded nano cap Aptevo Therapeutics (APVO +45.0%) jumps on a whopping 292x surge in volume in reaction to its announcement that it will receive a ro
   Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?  2020/06/25 14:35:00 PR Newswire
NEW YORK, June 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EKSO, AAPL, GNC, MSFT, and APVO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar  2020/06/25 13:00:00 Yahoo Finance
SEATTLE, WA / ACCESSWIRE / June 25, 2020 / Aptevo Therapeutics Inc. (APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will receive a royalty from Pfizer related to sales of
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アプテボ・セラピュ―ティクス APVO Aptevo Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)